AAIC 2025 Abstract

Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)

Trial in peopleInterventions

Abstract

Background: Cognitive intervention therapy has been proven to be a safe and effective technique for improving cognitive function in patients with mild cognitive impairment (MCI).

The paper

Hanyang University Guri Hospital; Rowan Corporation

AAIC 2025 Abstract, 25 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70859_102394